Pathogenesis of Clots Following SARS-CoV-2 Vaccine Suggests Choice of Treatments

Pathologic antibodies to platelet factor 4 in patients who developed clots after the AstraZeneca vaccine indicates treatment include non-heparin anticoagulant.

Read the full article here

Related Articles